Podcast appearances and mentions of George Whitesides

Presupuesto de Trump impulsa a SpaceX mientras recorta 24 % del dinero para NASA  Por Félix Riaño @LocutorCo   El nuevo presupuesto del presidente Donald Trump propone recortar en más de 6 mil millones de dólares el dinero para la NASA en 2026. Es el mayor recorte propuesto a la agencia espacial en toda su historia. Mientras tanto, esos fondos no desaparecen: se redirigen hacia programas de defensa espacial y hacia compañías privadas como SpaceX, que podrían recibir miles de millones en nuevos contratos. El plan sugiere eliminar el cohete SLS de Boeing y la cápsula Orión de Lockheed Martin, pilares de las misiones Artemisa, y en su lugar usar cohetes más económicos fabricados por empresas como SpaceX y Blue Origin. También busca cancelar la estación lunar Gateway, un proyecto internacional en el que participan Europa, Japón, Canadá y Emiratos Árabes Unidos. En paralelo, se propone aumentar mil millones de dólares para misiones a Marte, alineándose con el sueño de Elon Musk de colonizar el planeta rojo. ¿Es esto un impulso a la innovación o una apuesta riesgosa que pone en pausa la ciencia y las alianzas internacionales?  El plan desplaza contratos clave hacia empresas privadas estadounidenses.  La propuesta del presupuesto federal de 2026, publicada justo en el Día Nacional del Espacio, plantea una nueva visión sobre cómo y con quién se explora el universo. Mientras que otros años se había celebrado la cooperación internacional y el avance científico como pilares de la NASA, este documento concentra los recursos en programas más comerciales y militares. Se trata de una reorientación hacia el espacio como escenario de competencia económica y estratégica. SpaceX, empresa de Elon Musk, aparece como protagonista principal en esta nueva etapa. Actualmente, ya es la contratista más grande del Pentágono y de la NASA, y este presupuesto le abriría aún más puertas. Las inversiones más ambiciosas se concentran en dos objetivos concretos: la defensa antimisiles desde el espacio y los viajes tripulados a Marte. La empresa ha estado preparando su nave Starship justamente con este propósito. Si se aprueba este plan, Estados Unidos cambiaría su enfoque del conocimiento científico hacia la conquista y protección desde el espacio.  El cambio de prioridades ha despertado preocupaciones entre científicos, académicos y expertos en política espacial. La propuesta recorta en un 47 % el presupuesto de ciencia de la NASA, lo que afectaría satélites para monitorear el clima, misiones robóticas a otros planetas y programas de observación del universo profundo. Además, pone en riesgo miles de empleos científicos y técnicos. La estación Gateway, que serviría como plataforma para futuras misiones a la Luna y Marte, sería cancelada, lo cual afecta acuerdos con Japón, Canadá, Europa y Emiratos Árabes Unidos. La Estación Espacial Internacional también enfrentaría recortes: menos astronautas, menos experimentos y una retirada anticipada en 2030. Para muchos, esta propuesta no es solo un cambio presupuestal, sino una transformación del modelo de cooperación científica por uno centrado en el interés nacional y privado. Organizaciones como The Planetary Society advierten que el presupuesto es una amenaza directa a la formación de nuevos científicos y al liderazgo global de Estados Unidos en exploración espacial.  Aunque este presupuesto aún debe ser aprobado por el Congreso, ya está generando un fuerte debate. La congresista Grace Meng dijo que los recortes son "impactantes" y que destruirán años de trabajo de investigadores y educadores. Otros legisladores, como George Whitesides, aseguran que este sería el ataque más fuerte a la NASA en décadas. Del lado empresarial, hay quienes celebran el giro hacia sistemas “más eficientes” y dicen que los cohetes de SpaceX y Blue Origin pueden hacer lo mismo que el SLS, pero con menos dinero. El propio Elon Musk ha sugerido retirar la Estación Espacial antes de 2030 y usar los recursos para su visión marciana. Mientras tanto, la NASA sigue construyendo el cohete SLS y la cápsula Orión para las misiones Artemisa 3 y 4, que ya están en marcha. Los ingenieros que trabajan en estos proyectos piden claridad, mientras las alianzas internacionales esperan señales oficiales. En el fondo, esta discusión refleja una tensión entre dos modelos: la ciencia pública con alianzas globales, y la exploración comercial con fines estratégicos.  Durante el año fiscal 2024, SpaceX ya había asegurado contratos por 3.800 millones de dólares. En total, desde su fundación, la empresa ha recibido más de 18.000 millones en contratos federales. Uno de sus mayores logros recientes es el contrato para desorbitar la Estación Espacial Internacional cuando termine su vida útil. Ese trabajo está valorado en 843 millones. También está construyendo la nave Starship, pensada para llegar a Marte y que ya ha sido elegida por la NASA para aterrizar en la Luna durante la misión Artemisa 3. Por otro lado, Boeing y Lockheed Martin enfrentan la posible cancelación de sus contratos, pese a haber invertido décadas en el desarrollo de las misiones actuales. Mientras SpaceX avanza con cohetes reutilizables, las grandes contratistas tradicionales quedan en una posición incierta. Japón, que tenía previsto enviar a su primer astronauta a la Luna como parte del programa Artemisa, también ve peligrar su participación. Las decisiones sobre estos temas aún están en manos del Congreso, que deberá decidir si sigue esta nueva ruta o defiende el modelo científico tradicional.  Trump propone una reestructuración espacial: más fondos para SpaceX, menos para ciencia pública. Marte y defensa ganan protagonismo, mientras NASA pierde apoyo internacional. ¿Es esto el futuro de la exploración espacial? Te invito a seguir escuchando Flash Diario en Spotify y comentar tu opinión.  Bibliografía:The New York Times  Reuters  Spaceflight Now  Planetary Society  Conviértete en un seguidor de este podcast: https://www.spreaker.com/podcast/flash-diario-de-el-siglo-21-es-hoy--5835407/support.

Congressman George Whitesides has been warning about catastrophic wildfires in California even before he was elected to one of the most competitive House districts in the country in November. Now, the freshman lawmaker and former aerospace executive represents an area of northern Los Angeles grappling with a new wildfire that ignited on Wednesday. Whitesides joins Marisa and Scott to talk about the Hughes Fire, policies to prevent "megafires" and President Trump's executive actions on immigration. Learn more about your ad choices. Visit megaphone.fm/adchoices

Multiple fires continue to burn uncontrolled across southern California. Plus, former President Jimmy Carter returns to Plains, GA for his final burial. And, as people step up to help the Los Angeles community, California native and Oscar-winning Actress Jamie Lee Curtis pledges $1 million to help with the relief effort. She sits down with Stephanie for a wide ranging interview. Morgan Chesky, Jennifer Bjorklund, Tricia Cosentino, Rep. George Whitesides, Darrin Hurwitz, Peter Baker, Joyce Vance, and Jamie Lee Curtis join the 11th Hour this Thursday.

We often view paradise as a place of safety, beauty, tranquility. It's an ideal we long for, but one we can rarely find. This hour, TED speakers search for utopia and come to terms with reality. Guests include wildfire expert George Whitesides, author Pico Iyer, physicist Ramón Méndez Galain, and tech entrepreneur Ramona Pierson. We also hear from two residents of Paradise, California, Richard and Zetta Gore. Original broadcast date: November 10, 2023TED Radio Hour+ subscribers now get access to bonus episodes, with more ideas from TED speakers and a behind the scenes look with our producers. A Plus subscription also lets you listen to regular episodes (like this one!) without sponsors. Sign-up at plus.npr.org/ted.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Tonight on The Last Word: Donald Trump picks a Fox host to serve as defense secretary. Also, Trump allies push for Rick Scott as the Senate GOP leader. Plus, Senate Democrats race to confirm judges before the next Trump administration. And a former NASA official flips a GOP House seat in California. E.J. Dionne, Stuart Stevens, Sen. Amy Klobuchar, and Rep.-elect George Whitesides join Lawrence O'Donnell.

Segment 5- Liam Payne/Dodgers/ Red Flag Alert//Smile InfestiousSegment 6- Food BabeSegment 7- 27th district George WhitesidesSegment 8- Day of the Dead//Vetfest

Today on AirTalk, Israel-Iran tensions escalate to ground invasion. Also on the show, the Triple Play look at the Dodgers path to the World Series; everything you need to know about bonds ahead of the election, a new book from NPR music looks at the women who defined genres; and more.    Israel-Iran tensions escalate (00:17) District 45: meet Derek Tran (21:13) Triple Play: baseball season recap (34:50) CA 27: meet George Whitesides (51:22) What is a bond? (1:06:42) Previewing the VP debate (1:12:59) ‘How Women Made Music' book (1:27:20)

On this week's episode of “The Sunday Show” with Charles Blow in for Jonathan Capehart: Face off. How Vice President Kamala Harris is preparing for her first presidential debate with Donald Trump, and their first ever face-to-face meeting. Mitch Landrieu, National Co-Chair of the Harris Walz campaign, offers some insight on what the VP hopes to accomplish on the debate stage, and how she'll handle what Donald Trump throws at her. The Young and The Worried: New insight on what Gen Z voters are thinking as the election draws near and the surprising divide among young men and women. And Converting Conservatives: Liz Cheney has a new message to fellow Republicans after revealing she and her father Dick Cheney are supporting Kamala Harris over Donald Trump. Plus, a new lawsuit from several major publishers and top-selling authors over Florida's controversial book restriction law. We'll break down what the lawsuit highlights -- and what it won't challenge. All that and more on “The Sunday Show” with guest host Charles Blow.

August 12, 2024For this edition of PSYCHOTIC BUMP SCHOOL, DJ ROME welcomes JEFFREY KELLER, JASON SUGARS, & DR. SANFORD RICHMOND to discuss the newly formed presidential ticket consisting of VP KAMALA HARRIS & Minnesota Governor TIM WALZ. ROME also discuss with the panelists passionate sentiments (past & present) from Black men offering endorsements full of contrition now in favor of KAMALA HARRIS. Lastly, control of the House of Representatives runs straight through CALIFORNIA so get ready for a rundown of 4 critical races that will decide the majority that feature ADAM GRAY (middle top), RUDY SALAS (right bottom), GEORGE WHITESIDES (right top), & WILL ROLLINS (middle bottom) in very close contested races. A highly informative episode so press PLAY and SHARE with your loved ones.Adam Gray: https://www.adamgrayforcongress.com/Rudy Salas: https://rudysalas.com/George Whitesides: https://www.georgewhitesides.com/Will Rollins: https://willrollinsforcongress.com/

August 12, 2024For this edition of PSYCHOTIC BUMP SCHOOL, DJ ROME welcomes JEFFREY KELLER, JASON SUGARS, & DR. SANFORD RICHMOND to discuss the newly formed presidential ticket consisting of VP KAMALA HARRIS & Minnesota Governor TIM WALZ. ROME also discuss with the panelists passionate sentiments (past & present) from Black men offering endorsements full of contrition now in favor of KAMALA HARRIS. Lastly, control of the House of Representatives runs straight through CALIFORNIA so get ready for a rundown of 4 critical races that will decide the majority that feature ADAM GRAY (middle top), RUDY SALAS (right bottom), GEORGE WHITESIDES (right top), & WILL ROLLINS (middle bottom) in very close contested races. A highly informative episode so press PLAY and SHARE with your loved ones.Adam Gray: https://www.adamgrayforcongress.com/Rudy Salas: https://rudysalas.com/George Whitesides: https://www.georgewhitesides.com/Will Rollins: https://willrollinsforcongress.com/

The Origin Story Podcast host Ian Dunt previews the massive victories Labor will soon achieve in the UK. Check My Ads' Nandini Jammi details her efforts to get the MAGA-loving disinformation site The Gateway Pundit kicked off ad exchanges. Congressional candidate George Whitesides details his run against extremely vulnerable Rep. Mike Garcia.See omnystudio.com/listener for privacy information.

I've gotten to spend a little bit of time with Rob Shepherd over the years. He's working on soft robotics and all the different kinds of materials advancements that could really help us make robots that are more naturally integrated into the world. Things like polymer colloidal suspensions as inks for 3d printers so they can fabricate microfluidic devices, synthesizing single micron to millimeter scale parts in glass and silicon and all kinds of other stuff, like tiny gears. Imagine if you were trying to make a micro machinery like Swiss watches, but smaller. That's the kind of stuff that he worked on in the past and researched, developing pneumatic actuators, different kinds of elastomers and things that could maybe give us a real kind of muscles for robots. Also developing the kinds of walking and undulating movements that you would want robots to do once they got beyond just being these kind of rigid jerky things that we have now. This also gets really interesting when you're trying to make fingers for robots, which I'm personally obsessed with. I think it is a kingpin that's going to enable robots to start going to all the places they haven't been able to. We've seen some real progress on that lately. Rob is a great guy, super humble, willing to share everything he knows, which is a lot. Rob is an associate professor at the Sibley School of Mechanical and Aerospace Engineering at Cornell university. We recorded this in Ojai, California in a In-n-out Burger, on a Friday night, when it was full of teenagers... So this is it also an exercise in using AI for noise canceling, post-facto. I know it won't be the cleanest recording you've ever heard, but I think it will be interesting to know that we ran the audio through a tool called AUDO, and AUDO is one of many. I don't have anything to do with them. I've talked to the founders few times. I think it's cool. There's probably other ones, I don't know what the best ones are, but I've been using AUDO, and it's able to do this remarkable job cutting out, like a hundred noisy teenagers, while Rob and I are just sitting there eating burgers, talking about robots. So hopefully you'll learn something from that as well... Important Links: Cornell University Organic Robotic Labs Llume Cornell Engineering Robotics and Autonomy Advanced Manufacturing and Materials About Rob Shepherd Rob Shepherd received his B.S. (2002) and Ph.D. (2010) in Material Science at the University of Illinois where his research focused on developing polymeric and colloidal suspensions as 'inks' for 3D printers. He also fabricated microfluidic devices to synthesize single micron to millimeter scale parts. Concurrently to performing this research, he received his M.B.A. (2009) at U of I and started a company, worked with several other startups, and gained significant experience with the details of market research, financials, accounting issues, and legal aspects of entrepreneurship. In 2010, he continued his education as a post-doctoral fellow at Harvard University in George Whitesides's research group in the Department of Chemistry and Chemical Biology. In this group, he developed pneumatic actuators in soft elastomers that took the form of a machine capable of moving in multiple gaits: walking and undulating. These actuators have also been used for low-cost manipulators, and in concert with a microfluidic system for biomimetic camouflage & display.

Synopsis: In this episode of the Biotech2050 podcast, Dr. Mathai Mammen, CEO of FogPharma, shares valuable insights into the future trends of the biotech industry and the development of peptide-based therapeutics. Dr. Mammen's extensive career trajectory, from academia to leading pharmaceutical organizations, provides a comprehensive understanding of the industry's evolution and the pivotal roles he played at Theravance, Merck, and J&J. The episode delves into the significance of intracellular protein interactions and FogPharma's focus on developing helicon peptides to address this unmet need. Dr. Mammen's emphasis on a moonshot culture at FogPharma, coupled with his strategic approach to commercial success in biotech, makes this episode essential listening for executives in the biotech industry who are looking to stay ahead of future trends and gain insights into the innovative approaches shaping the industry's landscape. His profound knowledge and experience position him as a thought leader, offering invaluable perspectives on the challenges and opportunities in biotech, making this episode a compelling resource for industry executives seeking to implement strategies for commercial success in the biotech sector. Biography: Mathai Mammen is a world-renowned innovator in drug discovery, development, and team and company building. He brings significant global R&D and corporate leadership experience to his role as CEO, President and Chairman at FogPharma. Most recently, Mathai was a member of the executive committee at Johnson & Johnson, where he served as executive vice president of pharmaceuticals, R&D. During his tenure, he spearheaded a significant evolution of Janssen's R&D, one of the largest R&D organizations in the world. Mathai was a key leader in Johnson & Johnson's bold foray into COVID vaccines and he helped drive Janssen's substantial growth to become one of the top pharmaceutical companies globally. Under Mathai's leadership, Janssen R&D executed 40+ acquisitions and licenses and 350+ strategic partnerships and collaborations. A central pillar of his strategy was data science, which he used to couple recent revolutionary advances in data, compute and algorithmic approaches to every aspect of discovering and developing medicines. Mathai led his team to global approvals of eight new medicines, including Tremfya™, Darzalex Faspro™, Balversa™, Carvykti™, Rybrevant™, Ponvory™, Spravato™ and Tecvayli™, with many additional global approvals for expanded indications of marketed products. Prior to his role at Johnson & Johnson, Mathai served as senior vice president at Merck, where he was responsible for multiple research areas, including cardiovascular, metabolic and renal diseases, immunology, oncology and immuno-oncology. Before Merck, he led R&D at Theravance, Inc., a company he co-founded out of graduate school based on his work at Harvard University with Dr. George Whitesides. Under his leadership, Theravance advanced a robust pipeline of multiple development-stage compounds resulting in five approved pharmaceutical products, and separated into two companies: Theravance Biopharma, Inc. and Innoviva, Inc. In addition to his extensive corporate experience, Mathai currently serves on the board of directors of 10x Genomics, Inc. He has authored more than 150 peer-reviewed publications and patents. Mathai holds an M.D. from the Harvard Medical School and Massachusetts Institute of Technology (HST) and a Ph.D. in chemistry from Harvard University.

This podcast is a commentary and does not contain any copyrighted material of the reference source. We strongly recommend accessing/buying the reference source at the same time. ■Reference Source https://www.ted.com/talks/george_whitesides_a_lab_the_size_of_a_postage_stamp ■Post on this topic (You can get FREE learning materials!) https://englist.me/168-academic-words-reference-from-george-whitesides-a-lab-the-size-of-a-postage-stamp-ted-talk/ ■Youtube Video https://youtu.be/Qg2DLw4ma1c (All Words) https://youtu.be/hQR7AmwiRiU (Advanced Words) https://youtu.be/NRIUdjD3xyY (Quick Look) ■Top Page for Further Materials https://englist.me/ ■SNS (Please follow!)

This podcast is a commentary and does not contain any copyrighted material of the reference source. We strongly recommend accessing/buying the reference source at the same time. ■Reference Source https://www.ted.com/talks/george_whitesides_toward_a_science_of_simplicity ■Post on this topic (You can get FREE learning materials!) https://englist.me/171-academic-words-reference-from-george-whitesides-toward-a-science-of-simplicity-ted-talk/ ■Youtube Video https://youtu.be/ocCfo52j0vg (All Words) https://youtu.be/XIzGeuwW44k (Advanced Words) https://youtu.be/OptEZUfX6jY (Quick Look) ■Top Page for Further Materials https://englist.me/ ■SNS (Please follow!)

Some parts of this conversation is done by AI voice cloning.

  In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Alok Tayi, Founder and CEO at Vibe Bio.   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Alok, covering:   The personal story that motivated and inspired Alok to create a rare disease platform focused entirely on creating an ecosystem focused on high potential medicines. Lessons from ‘the grind' of raising over $100m in capital, and why you need a ‘Minimal Viable Investor' (MVI) The macro impact of Covid-19 in highlighting the importance of medicines - and why this is a time for optimism, innovation and technology in biotech. The catch-22 of inflection points for biotechs and how that impacts access to capital. And whether AI could play a pivotal role. How CDMOs and CROs need to evolve away from just the fee-for-service model to explore longer-term, partnership-led alternatives.   Alok has 15 years of experience as a scientist and 12 as a serial entrepreneur. After completing postdoctoral work at Harvard University with George Whitesides, Alok started two pharma SaaS companies, PreScouter and TetraScience, which employ several hundred people combined and have more than four hundred customers. He also launched and led the life sciences division of Egnyte, a cloud content governance company based in California, and grew the business to a 60-person team and eight-figure run rate.   Alok founded Vibe Bio after his daughter was hospitalized at birth and he learned first-hand that the biggest obstacle to developing treatments isn't finding potential therapies — it's funding them. Vibe Bio is helping patients in similar situations overcome that obstacle by scaling the development of treatments for rare disorders sustainably for the first time. He holds a B.S. from Cornell and a Ph.D. from Northwestern, both in Materials Science & Engineering.   Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!   Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.  

I asked George Whitesides For Final Words, And This Was His Response :D by Marwa ElDiwiny

Show Notes: Ruth Hertzman-Miller, a member of the Harvard and Radcliffe class of 1992, graduated with a degree in biology and went on to a career in medicine, completing a residency in internal medicine at Cambridge City Hospital and a fellowship in health services research in Los Angeles. After returning to the Boston area, she worked as a physician at Cambridge Health Alliance and then at NewBridge, a retirement community. Ruth discussed her journey since graduating, reflecting on the unexpected twists and turns it has taken. Ruth made the difficult decision to switch from medicine to music four or five years ago. She took catch up courses at a conservatory in Boston and is now doing a master's in composition. Ruth is a pianist and choral singer and was inspired to pursue music again when her seven year old daughter joined North Cambridge Family Opera. An Education and Career in Medicine She didn't know what she wanted to do with her life when she went to college, but her dad and grandfather were both psychiatrists, so she figured she'd take some premed courses and see what happened since she liked science and helping people, but she also got to take electives in other subjects like music. In medical school at Case Western, she was interested in the clinical aspects of the program where she was assigned to a pregnant woman and followed her through delivery and the baby's first year of life, but along the way, she had many doubts about how much she wanted to be in the program.  At the end of her internship year, she went to her residency director and was considering quitting, but he talked her into staying.  Balancing Family Life and Work After the birth of her first child, she found it difficult to focus on both the intense schedule of work and study and family, but she finished her master's and eventually made the decision to pursue a master's in music and wrap up her medical career. Ruth balanced work and motherhood for many decades. Initially, she worked at Cambridge Health Alliance and then various medical but non-clinical jobs such as the Joslin Diabetes Clinic and the Hearst Company, and then at EBSCO Publishing. While she was in non-clinical positions, she worked clinically one day a week at Cambridge Health Alliance and then at various sites within Hebrew Rehab, finally landing at the NewBridge retirement community. When she decided to cut down on her work and dedicate more time to music, she kept her one day a week job at Hebrew Rehab and started studying for a certificate in music. Studying Musical Composition and Theory Ruth discusses her experience studying composition and writing music and what was included in  the coursework. As a composer, she is interested in exploring the form of music. She studies what has been done in the past, the many options and choices available, and considers how she can create something new. She refers to Mozart and Haydn, who approached their compositions differently and how they did so. Ruth is not expecting to make a professional career out of her work, as it is difficult for a composer to make money, but instead, is more interested in exploring new forms and having her work performed. Video game music and film music are some of the biggest markets for composers; however, Ruth is not particularly interested in these areas. She is more interested in writing for small ensembles such as string quartets, for which she can find performers without much difficulty. She also talks about the place of AI in composing music, and how it can provide inspiration but needs human intervention to create a finished product.  The Creative Process of Composing Music When asked if composing music feels three-dimensional, or if it has different mental qualities, Ruth answers that this is subjective and depends on the individual, but it is likely that the experience of composing music entails a combination of physical and mental elements. It requires both the ability to think in abstract terms, as well as the creative ability to visualize and construct musical ideas. It is a process that is both intuitive and analytical, where the creative elements of music are balanced with the technical aspects of composition. Ruth talks about the creative process behind composition. She explains that she typically has a broad idea, such as writing a piano piece with two players starting at opposite ends of the piano, and then breaks it down into smaller details such as melody and harmony. She then works on generating variations on the material and figuring out the logical progression of the piece. She explains that she usually isn't trying to express something that can be explained in words, but rather it is usually a feeling or an exploration of the music itself. She uses the example of a recent project to explain the process. Ruth also  talks about conveying emotions through music. For some pieces of music, the goal is to introduce the theme to the audience and have them understand it through the different changes in the music. At the opposite end of this, there is writing an opera scene where the focus is more on portraying the emotions. Professors and Courses of Influence Favorite professors and courses from Harvard include Luise Vosgerchian's course on the Development of the String Quartet and John Stewart's course on Introductory Music Theory. She also talks about her more recent professor, Lyle Davidson, who happens to be in the same tradition of Luise Vosgerchian. Other favorite courses include Biology of Fishes with Karel Liem, Scientific Ethics with George Whitesides, Moral Reasoning with Thomas Scanlon, and Marjorie Garber on Shakespeare. Timestamps: 01:41 Pursuing Music After a Career in Medicine  05:19 Motivation and Commitment During Medical School  09:57 Medical Training and Fellowship  16:28 The Process of Studying Composition  20:28 Composing and Making a Career in Music 25:32 Reading and Generative AI in Music Composition  28:03 Exploring the Creative Process of Composing Music 36:05 Music Study and Harvard College Professors  Links: YouTube: https://www.youtube.com/@ruthhertzman-miller3349/videos

We have seen how gas stations have changed the way humans can travel. So what if there was a gas station on the moon? On today's episode, hosts Olivia Lambertson and Riya Jain interview Dr. George Whitesides, a Woodford L. and Ann A. Flowers University Research Professor at Harvard University. Hosts Bella Liguori and Olivia unpack the contents of the interview including discussion on the Lorenz effect, why we should follow our curiosity, and how high costs cause problems in industry. We hope you enjoy! If you would like to know more about Dr. George Whitesides  you can check out his research or reach him by email at gwhitesides@gmwgroup.harvard.edu. About us: ChemTalk is a small student-led and ad-free non-profit working to become the top chemistry education platform in the country. Please support us by following our social media channels, sharing our content, and donating if possible. You can access our website for videos, articles, and tutorials on general, organic, and biochemistry. We also have a VERY cool interactive periodic table, articles about the elements and their properties, and experiment demos. ChemTalk is on TikTok, Instagram, Facebook, and Twitter which you can access here. Thank you for listening and see you next time!

Clip: George Whitesides " The Lab Is Very Different From Reality And Who should Lead it?" by Marwa ElDiwiny

She listens to quakes in stars far, far away, to help predict if they host earth-like planets. He makes it possible to build factories so small you can't even see them.

Thank you for your support for Season 2! We reflect and look forward to Season 3 on this episode! Learn more about our co-hosts below! Alok Tayi, PhD is the Co-founder and CEO of Vibe Bio. Vibe is a therapeutics company that partners with patient communities to develop new medicines. Previously, Alok spent 10 years as an entrepreneur and life sciences software executive. He started and built the Life Sciences business unit at Egnyte, was a YCombinator-backed founder and started two SaaaS companies. Prior to his career in software, Alok spent over 15 years as a scientist, including postdoctoral work at Harvard University with George Whitesides. Alok holds a PhD from Northwestern University and BS from Cornell University. Rahul Chaturvedi is the Founder and CEO of Clora, the leading marketplace where people go to discover, build, and manage on-demand life science teams. Prior to founding Clora in 2017, Rahul was the head of clinical development at several biopharma companies, such as Kaleido Biosciences (NSDQ: KLDO) and Avedro (acquired by Glaukos). Rahul has successfully led the development activities for 20+ Phase II/III programs that have resulted in 6 product approvals to date. Rahul holds a bachelor of science degree from Brandeis University.

In this episode, I read a short essay I wrote on effective scientific writing, with references to Strunk and White, Steven Pinker, and George Whitesides. The original article was published in Chemistry of Materials, 2021, 33, 11, 3865–3867, original publication date, June 8, 2021. https://doi.org/10.1021/acs.chemmater... This reading was done with permission from the American Chemical Society.

In this episode, I respond to questions related to scientific writing, and coming up with new ideas in scientific research. To what extent should we minimize jargon in scientific writing? Is it acceptable to use literary techniques like metaphor in scientific writing? If I have a lot of data for a single figure, how do I organize it so that the figure isn't overwhelming? Different readers are expecting to get different things from a paper. How do you organize the content, and what do you put in each section, from the title to the methods? (Credit to George Whitesides in my description of what should be in the first introductory paragraph of a paper.) How do you write the abstract to draw the reader in? What's the difference between the abstract and the introduction? How do you select a research topic that combines separate disciplines? Should you “follow your passion” or focus on developing skills? How do you know how your own skills can help inform the selection of a research topic? Should one expect their skills and their passion to align?

One of my students interviewed me for a class on leadership. I was honored he chose me for this assignment. Here are some of the topics we covered: What were some formative experiences that influenced your career trajectory? Is it better to seek a range of experiences or to focus in a single area? What are the values that underlie effective leadership in research? Do you have a mentor or role model? What advice would you give to a college undergraduate about to enter the job market, especially during Covid?

Thank you for your support for Season 1! We reflect and look forward to Season 2 on this episode! Learn more about our co-hosts below! Alok Tayi is the Vice President of Life Sciences at Egnyte where he is responsible for building and executing the company's strategy for the life sciences market segment. Alok works across the organization to verticalize our marketing, sales, product, compliance, and account management practices for this domain. Before joining Egnyte, Alok was a YCombinator-backed entrepreneur and started two vertical software-as-a-service companies. Prior to his career in software, Alok spent over 15 years as a scientist: he took part in postdoctoral work at Harvard University with George Whitesides, and has published papers in Nature and Nature Chemistry. Alok holds a PhD from Northwestern University and BS from Cornell University. Rahul Chaturvedi is the Founder and CEO of Clora, the leading marketplace where people go to discover, build, and manage on-demand life science teams. Prior to founding Clora in 2017, Rahul was the head of clinical development at several biopharma companies, such as Kaleido Biosciences (NSDQ: KLDO) and Avedro (acquired by Glaukos). Rahul has successfully led the development activities for 20+ Phase II/III programs that have resulted in 6 product approvals to date. Rahul holds a bachelor of science degree from Brandeis University.

My approach to scientific writing with guidance inspired by Steven Pinker, George Whitesides, and Anne Lamott. I hope you find something in here useful or interesting!

The New Frontier is new again: after years of stagnation, emerging players have reignited the space race in the 21st century. Dramatic technological advances and lucrative business models have changed the conversation, and private companies are making up for lost time. Countries like Japan, China, India and the Emirates are jumping in, too, expanding the borders of geopolitics to new heights. George Whitesides, CEO of the spaceflight company Virgin Galactic, joined Altamar to discuss the future of space travel. The interview came on the heels of a major announcement – Virgin Galactic and NASA are opening a private astronaut program with public accessibility. Previously, Whitesides served as NASA’s Chief of Staff after working on Obama’s transition team for the agency. He’s also served as the Executive Director of the National Space Society and is an advisor for companies and organizations such as the FAA Space Transportation Division, COMSTAC, the Space Generation Foundation, and the Zero Gravity Corporation, among others.   https://altamar.us/space-is-back/ Follow us on Twitter and Facebook  ----- Produced by Simpler Media

With the beautiful Spaceport America as the backdrop, Edwin continues his conversation with  George Whitesides, CEO of Virgin Galactic and The Spaceship Company. George is the former Chief of Staff for NASA, and today leads Richard Branson’s company working to bring about commercial spaceflight. George and Edwin discuss the Virgin Galactic spaceflight experience, Virgin Galactic’s journey to this point, George’s predictions for the next big milestones in space travel, and what George is most looking forward to as Virgin Galactic prepares to send every day people into space. 

Edwin takes a ride with George Whitesides, CEO of Virgin Galactic and The Spaceship Company.  George is the former Chief of Staff for NASA, and today leads Richard Branson’s company working to bring commercial spaceflight to everyday people. We ride in a Range Rover V8 Supercharged from Las Cruces, New Mexico to beautiful Spaceport America and discuss the future of space travel.Come along for the ride as Edwin and George discuss a few topics including: George's tenure as the Chief of Staff for NASAThe united States move to privatize low earth orbit travel which gave rise to companies like Virgin Galactic, Elon Musk's SpaceX, and Jeff Bezos' Blue OriginSpaceport America, the White Sands Missile Range and New Mexico's history and role in today's commercial space programThe potential for life on other planets

How do you photograph the unphotographable? In this episode we interview MIT research scientist Felice Frankel, who specializes in visualizing science, using pictures to draw audiences in and help scientists more deeply examine their own work, including nanoscale materials that are smaller than wavelengths of light! We also have a mini-interview with graduate student Paige Kinsley about how COVID-19 is affecting chemistry labs in the Center for Sustainable Nanotechnology.(photos by Miriam Krause)Want more podcast episodes? You can find them all on our podcast page, or you can subscribe through Apple Podcasts or Stitcher.ABOUT THIS EPISODERelated links:Felice FrankelBooks: Modern Landscape Architecture, Picturing Science & Engineering, No Small MatterStephen J. Gould; E.O. Wilson; George Whitesides; Don EiglerSustainable Nano blog posts: Ferrofluid, gold color & surface plasmon resonanceThe Center for Sustainable NanotechnologyInterviewees: Felice Frankel & Paige KinsleyInterviewer: Stephanie MitchellEditor: Natalie Hudson-SmithProducer/Host: Miriam KrauseMusic: PC III and Dexter BritainThis material is based upon work supported by the National Science Foundation under the Center for Sustainable Nanotechnology, grant number CHE-1503408. Any opinions, findings, and conclusions or recommendations expressed on this podcast are those of the participants and do not necessarily reflect the views of the National Science Foundation or the participating institutions.

United in Hope: Astronauts George Whitesides, Peggy Whitson, Anousheh Ansari, Rusty Schweickart

Hello everyone it is now time for gut check project COVID file number four. We have an incredible guest today with joining your host Dr. Ken Brown. We how now have Mr. Chris Austin from Waxahachie, Texas. He is here with sea long medical and you may have seen some of his incredible essentially their vent hoods they are hyperbaric vent hoods that allow people to breathe better. Chris, thank you so much for taking time out of I know is a very busy morning as you prepare for for more work at sea long medical down here in Waxahachie. How are you doing?Oh, we're doing well. We're, we're we're feeling good. Oh, no. And first of all, I need to apologize a little bit. It's starting already. My voice starts to go away. Early and earlier every day because of so much talking and stuff we do but anyway, we're doing well just not much sleep and a whole lot of talking but it's all it's all great. It's all wonderful. People are being so, so supportive, it's just I can't even get my head around it still. Well, no, it's it's awesome. We're obviously in the middle of the pandemic here with the with the COVID crisis but can you want to speak a little bit about what it is that you saw on the TV and why you called me and how I ended up reaching out to Chris.Absolutely. I may sound a little different because the internet went out of the studio so I'm doing this by phone so that's yeah, so you and I are feeling the same thing here. So I was watching and I kind of joke about this that I've actually become my dad and I like 60 minutes now so a lot 60 minutes.My granddad so don't...I'm with you there.And they did this incredible segment. First of all, they they lead up to it with this with the the stress that the New York doctors are under followed by nurse segment, which was just incredible, and I don't want give anything away but I just sat down with holy cow, he's a neighbor. We're here in Dallas, you're in Waxahachie, Texas, and fortunately, like a like a good Texan you woke up early and agreed to do this interview just because you're a nice guy, so it's pretty exciting.Well that's I appreciate all that but I we're up, we've been up working here for over an hour already. We've been starting at six because of the crisis and staying here til two in the morning the other day, I was there till four in the morning day before yesterday. Just the way it flows go. So, but thank you very much. So Chris, before we started the interview, you let me know that sea long medical has been around basically doing these hyperbaric helmets since 1985. But you ended up acquiring the company and moving it from Kentucky down to Waxahachie, Texas back in 2016. What drew Chris Austin to sea long medical and then to bring it down here to Waxahachie?That's good question the, the whole thing started because we have a mutual friend who lived up by Lake Possum Kingdom. And he manufactures hyperbaric hoods does a company called tekna industries and through mutual friends and something like that we became friends. And I have diabetes. So I have neuropathy pretty bad. And was having a lot of problems with my legs. Can you say, Chris, come up here. Let's do some dives. Let's fix that and I didn't really know anything about it at the time. So I said I wanted to come see him anyway it's a beautiful area up there. I went up and staying awhile and took took some treatments, a week's worth of treatments and it's It was incredibly incredibly life changing what happened. I could drastically reduce my insulin. The...neuropathy I'm sorry, it's just went away for not not forever it was gone for about a month. So it was definitely a you know, a changing event for me. I mean it was a whole bunch of other things happened that some people say doesn't happen but my eyesight got better my hearing my sense of smell. You know, it's like a Popeye when I ate this big can of spinach kind of and I said, you know what last getting off track here kinda I used the sea long hood. That's what I use for my treatments. And because that's what he uses. He wasn't he was pretty good friends but pretty good friends with the previous owner and after a while I've gone back and done several more and same results. And he called me. Philip called me and said, Chris, I need to talk to you. So okay, great. No problem. Got up there and did another treatment. And he said, you know, that product you're using, that's hood. Yeah, that's pretty cool. He goes, it's probably going to go out of business. The owners have been around a long time, and they're ready to, you know, retire and move on. And nobody has taken up on his offer to buy the company. And he stated that the company is so important and the product is so important. I really think you ought to buy it because I had just retired after 30 years as an aerospace engineer. Nice.Oh, wow.That's what we did.Wow, that is incredible. So I'm actually far more endeared to the story. You are drawn to it because of your own personal experience and benefit. You knew you needed to save the technology so that other people could have that benefit. That drew you into it. You were in retirement, you said that this is something that we can do. You had no idea that there's gonna be a pandemic, though around the corner in 2020, did you?Not really? But I'll tell you a huge cascade of events in my life for probably three or four years before that, Up to that time, and significantly after that time, made this all possible. No, it mandated it that this was going to happen. You know, we knew about the the aspects of the potential for a great life saving product for non invasive ventilation. And it just spoke, spoke to my heart and my mind right there said, this is what we're doing. This is our destiny. And that's why we're here.That's incredible. Wow.So You, you said that there was a gentleman who was at sea long. Was sea long medical created simply for the...the manufacturing of the hyperbaric helmet?Correct. No, no sea long...he, see here. That's a big, big story. But Hill-he previously owned a very large injection molding corporation. Okay. And a man by the name of shorty long, who was acquaintance of his, who was a professional deep sea diver said, I need something like this and it doesn't exist. They drew up a sketch on a napkin kind of thing. And the helmet was born. And shorty long said I don't I'm a diver. I've got a big diving business and stuff here. I don't want it...you run with it. You've already got all the equipment and all this. So I did.Well, you kind of hinted at it already because of your own revelations on how you began to feel better. I had a question written down which was to ask you before the COVID situation if if beyond the helmet being an intermediary step before or hopefully saving somebody from intubation, if there were specific diseases that it worked for but you already mentioned, retinopathy and diabetes, do you know if anybody like with sickle cell anemia what...are those are those types of patients that also benefit from this type of hyperbaric helmet? Well, as you guys know, in the medical field, there's there's a lot of things we have to tread lightly on as far as what we say.Oh, ok.No, I'm gonna say it. I'm just giving you that caveat up front. Because the vast vast majority of the indications that we have...I can't even count how many...people have told us this. Plus as we are so became so close to the industry and the and the the process I've personally seen been there and talked to amazing things. children with autism, PTSD course an incredible array of soft tissue damage. Incredible, incredible positive results for traumatic brain injury. And one of them in particular if you look up Joe Namath, you know, the famous New York Jets, quarterback, and few more, but he's got all kinds of stuff on the YouTube and various places about him telling his story about his whole life was changed due to 100 dives in a hyperbaric chamber. completely correct...completely corrected all of his brain damage. I can go I can go on with this kind of statement for hours and hours, just one after the other after the other.Chris, can I clarify something real quick, so does the helmet act like a hyperbaric chamber?No, it just provides well in the hyperbaric chamber, it provides the pure oxygen that works with, you know, the atmospheric pressure to about 3 ATA, or 60...70 feet you know something or something like that. And the pure oxygen coming into the respiratory system gets supercharged in every single cell in your body. Every cell gets this this amazing product that the cells know how to use to do their job. So all of a sudden, they start doing their job better than they ever have, and, you know, doing all kinds of great stuff in in cells, that a lot of people have said, no, you'll never regenerate these cells. Those cells are once they die, they're gone. That's not true, least for a vast majority of them, like brain cells and heart cells and things like that. And that'sPlus one thing I forgot to add probably the most important part is during the process of the hyperbaric treatments, your body starts producing a huge amount of its own pluripotent stem cells. So those cells now are happy and fed, they start grabbing all the stem cells and just go into work repairing stuff.Nice. Now that all of that all that makes makes complete sense with the way that we've tried to help and repair people neurogenically, etc. I've got another question for you and Ken and I debated on how how clinical that we wanted to get on this particular series, but where you're taking it's, it's almost inevitable. Part of the problem that some of the people are worried about, or the physicians are worried about with the patients now with COVID is that some of their red blood cells may actually lose a little bit of the oxygen carrying capacity. And they've decided that they may need to look at things that are hyperbaric and different different types of modalities that do exactly what you just talked about supercharge extra extemporaneous. I'm mispronouncing that word, but the extra cells around them. Is that something you found with the helmet that could work?Yeah, that's what it's for you bet it could work. That's awesome It does work. It has been working for that for 35 plus years. But one of the most important things too...I keep saying that but everything so they're all important is that...angiogenesis in your body starts forming new blood vessels and in getting blood to places that may have been either either starved due to previous conditions, or the body senses that nope now these things need to be repaired. For whatever reason it may be that you know the the virus could have done damage...just whatever reasons.So before the helmet came along, people were scrambling in the the word of street was we were going to run out of ventilators and everybody knows that usually in the ballpark of 10,000 12,000 is the low end on the amount of money that they'd have to spend per unit. Tell us a little bit about what the the helmet cost the medical community and where you've moved the price since then, Chris.Well, the the helmet before all this happened was $162 and 70 cents, and it's still $162 and 70 cents. That's the basic model, which at the time, we produced and provided that based on usage before, like Dr. Chris and others who were doing the testing, but once this, the COVID-19 epidemic started, we became much more popular and a larger number of doctors started using it and people started figuring out there's different things that can be done. There's different accessories, particularly Dr. Chris Patel, there's different accessories that really would help us. And they would send us videos and we'd correspond. And then we would go, we have a great team we pair with called impact. They would 3d print the stuff I'd sketch it all out on a piece of paper or something, and they and they would make the design and we come back and like we liked it, or we didn't like it, we'd send it to Dr. Pel, Dr. Chris and Dr. Patel, and they'd, you know, critique it and if it was a good product, we'd make it right there. We could have made in a matter of hours. Well, the 3d printer, ship it back to him. And we've made a bunch of improvements. So long story but we've got a significant number of additional accessories. And that's what makes it possible to use this without a ventilator or any type of equipment. All you need is wall oxygen and wall O2 and a special part that we created to plug that into the system, and a peep valve, and you can do all this with no equipment.Oh, that's incredible. That is incredible.That's the holy grail because in third world countries have people lined up in the halls, which is already happening in New York, Boston, New Jersey, Pennsylvania. You can treat them all with just just three quarter inch lines.Wow, that's great. Hey, when I saw the interview on 60 minutes, you did tell a very unique story about how somebody may have helped you infuse a little cash into the company.Yeah, talking about George Whitesides and Virgin Galactic. Been a locks up maximum no cash per se, which is another complete story. We've had no assistance from federal state local dog catchers nothing. Dog catchers.Which is good because Charlie, our security she'd be...no she's not good for a dog catcher. Oh, we were on Wall Street Journal first. That was first one to really contact me and Mr. Whitesides, who was the CEO of Virgin Galactic, called me up somehow he got got a link to me. Why do I get to a man named? Well go there, but uh, he's the Chris. I really liked what you do. What can we do to help? And we talked a little bit and I said, really what I need sir, is more RF welding machines. I mean we have a great partner in a company called Selectric up in New Jersey. Walker, the owner built four machines for us at risk, which means he didn't have any funds because I didn't have any money. He built them all...they were sitting there ready, all shiny, polished up ready to load into an 18 wheeler to bring down here and I still didn't have any money. So when I when I talk to Mr. Whitesides about that he goes, what's this guy's phone number? Gave him the phone number. We chatted and went our separate ways and about two hours later so Walter calls me and said somebody just called and paid your entire bill.That's awesome.So you know, praise God. Two days later they were here.And that's fantastic. And they're now up and running. Really first day with the full crew was yesterday. We've been slowly training people as they come in. Primarily most of them are all volunteers from very, very close locally to our location. Because we know we can't rely on someone who has a long commute or you know, we had to verify their their lifestyle. They don't continue to run around out there and go to Walmarts and all these places to get a potential for contracting the virus. So it took a little while to get the whole, get the whole crew. But the first day first full day was yesterday. And we hit our goal spot on for how many we created and was able to provide them to Pennsylvania. And who else? Several people that we really wanted to get them to the hotspots in saying that they shipped overnight yesterday.So how many you're able to produce in a 24 hour period with this full crew?Sorry, the, you know the first phase are always more difficult. These are new operators. We only had one experienced operator, which is our son, Chris Sr. And he was mostly spent training. So that that caveat is this was very slow training brand new people who had never done anything like this. So we still got over 200 out in one day, which was a good start, but we need to be and we will be. At least by next week we'll be knockin on a thousand. So that's our goal.That is amazing.Heck yeah.I have a quick question for you since I didn't realize that that was that I thought there was more equipment needed.Ventilator. All that kind of stuff, hooks on it too.Oh okay. Is there do you see any with your engineering background is there any way to modify it so that people with a C pap machine at home could use this in any particular way?We already do. C pap, bi pap, you know, ventilators, anything like that where you can control your positive pressure. But you don't need to do that. I'm looking for...all you need's a peep valve to control the outflow to maintain your desired pressure inside the helmet. And that's all you need. So you're gonna...you'll dial up the atmospheres basically what's going to be inside of the bariatric helm...the the helmetHappens to me all the time.Yeah, that's all the words, but you'll dial up the atmospheres or the amount of pressure that you want in there with that peep valve. Correct? And then...Yeah, and the source as long as you have a good clean viable relatively consistent source for the inflow, which we're finding new sources for that all the time. Sure. You just control the outflow to maintain the pressure inside.Well, you know, a lot of the patients who end up having problems with pneumonia lung collapse, for instance, it's because they lose that alveolus. Right? And it seems to me like what you've got here is something that Ken and I talked about in our last episode, which is how do we give someone positive and expiratory pressure? And one of the ways to do that is obviously by having a good steady form of peep. And this is far more comfortable than either a tube down the throat or a big face mask like a C pap or bipap mask. This just seems far more convenient. It allows the patient to not have something directly on their face. It's it's pretty incredibleIs there any chance you have the...The masks leak. I'm sorry, cellphone delays I'm used to this...masks leak, as you apply all of this pressure, they want to push it away from the patient's face. So you really can't get any kind of a ensured pressure. Unless you just strap the thing on like a you know, what is his name from scary movies, which is very uncomfortable and things like that. And they still have a large potential for leaking around the nose, and there's nothing against them. They're fantastic products. It's just not the best suited thing for this kind of positive pressure. I agree. Well, Chris, I see that you have turned your shoulder a little bit, and you might even have some equipment back there that you could probably show us on how it works. Unless, unless you're you know, unless you're embarrassed. I don't know but it looks like a pretty awesome piece of equipment to me. would you would you mind showing us how you apply it?Sure, hold on a second.This is great. I love this guy.What a cool situation. He just said I liked what this does. I'm gonna do this at home.This is the peep valve I know I had one sitting over under my chair. Oh nice. Well, that's kind of the...the hood itself...it has been for a long, long time, is basically a bubble I saw a space helmet. Clear trash can whatever you want to call it. The key is that this is made out of a very robust yet soft and clear material because we can sit...squash it down like this and I can easily ship and store and if I push them in like that, then we have the next sealed part, which this one's already been cut for me, you get a cut template way to measure your neck with a little tape measure and then when you cut this out and look closer you might see some graduated rings on it...well the instructions say okay, if your neck is 17 inches you cut the third ring from the top or something to that effect. And then once you have it cut for your neck and the cut rings apply an interference. In other words, people we've had a problem with people saying okay, well this is cut from my neck if I'm a 17 I cut it to this line that says 17, it won't be tight enough. So I need to cut another line to make it tight on me or loose on me. Don't do that. That's all figured in there. Right? Well, that's kind of one of the problems we have. People say oh, I leaked I leaked. I go, how did you do it? No, don't add or subtract cut it the way the paper says,Hey, while we're talking about that, what about somebody...and what about a woman with really long hair because you have to pull it up or a men with a hairy neck would we want to shave that or if they have like a central line, you just kind of go ahead and stay with the same cut just try to keep those things out of the way?No, it has to be out of the way it's dry. You want to do it for intubation, you have to do it. It's like people who are firefighters or other type of the profession and they use masks they have to shave their neck. So it's the same thing. So and this ring has two ports, which doesn't matter which one they're they're not directional. So you put the inflow and the outflow, into these ports. And that's the standard part. Oh, one thing this one's called accessory port. It's a tapered hollow cone per se with the same graduated lines. So if you want to put a feeding tube or another O2 line or sensors protecting oxygen or carbon monoxide, carbon dioxide, sorry we can do all that for you there. And then this is put on the patient's head, which I will do. And I'll just say that this is the easiest one there, to put on somebody's head, so first of all, it takes two or three people. Make sure it's got a good seal. Now it's on.Oh wow. That fast. Not exactly straight, but you get the idea. I do. And then this has got a big seal. Oh wow.And then you also have ports here. Or feeding lines here. It's not an add to it's kind of an instead of because some patients are more comfortable with it up here, some doctors like it here or say that, you know the where the host comes from. So from here from here below...I saw how quickly Chris, you're able to apply and then even more importantly, how fast you're able to disassemble it. So a concern of a patient that needed to be accessed, you know, like their airway would be it's incredibly rapid. It looks like to me like yeah, that's pretty effective. Nothing to it, nothing to it at all.And there's, because of this usage, we provide this type of a clip, which clips the two parts of the helmet together. So other larger pressures, they won't separate and it goes underneath there arm and one hooks in the back one hooks in the front and you have one under both arms so it folds it down very secured. And there's a quick release feature you can't see the little pin right there. All you gotta do is go pop and and the lines and everything separates. So it's basically virtually no delay still under three seconds.So do you have, is there a Is there a maximum pressure that's recommended for the helmet?Oh, that's depending on the respiratory therapist and the physicians. But we test every single part every single part to a half psi, which is far above anything they would ever need.Okay. And then what about like in tidal co2 measuring the respiratory rate do y'all have like a device or are you are you able just to use a normal sera port line to make that happen?Normal stuff. Yeah.That is incredible.I want to ask you a quick question about the University of Chicago study. When I was reading that it was stopped early because it was proven to be so much more effective that the mask that they that they didn't even need their number to actually completely enroll. It was so successful that they stopped early. How did you end up getting University Chicago involved?Well, they came to us because they knew they knew of the product and it was made in the USA and they like the the multi ports and several other aspects of it. And we also have a product we call multi patient. It actually has a different design, which you have the neck sealed part like this. See this comes right now, fully assembled ready to go. A seal sealed together with an O ring inside it so it's it's unable to leave. We have another one, that this part can be taken, taken apart after the fact. And then the patients only need their own neck seal portion. So you can reuse them over and over and over. And he really liked that, that aspect of it. So that's that's what he wanted, we were the only one that has that. So, but for this horrible virus, we have to make as many parts as possible, which is an unbelievable task. So we streamline it used to have a lot a complete line of a bunch of different things. And we've ceased production on on virtually everything except what you see right there. So we can pump out more of those. Because once you get rid of all the other stuff, we concentrate on just a small number of parts we can you can get much moreMan that is...that's an incredible piece of equipment. I wish that we'd we'd had that and been trained on that back in the anaesthesia education days. That's pretty awesome.This has gotta be one of those things that when when we show it to medical students 10 years from now, it'll be a revolutionary change and how we we treat people with ARDS with pneumonia with everything.No joke.And people are finding things it seems like every day but pretty much monthly, different applications, different benefits....exciting things that we find out, especially when we found out about autism, PTSD, brain, I mean brain damage I could go on and on and on several autoimmune diseases and the only thing that it really got used for prior to this because we can never get any traction at all with other than Chicago and a couple of other places that have been doing studies, like Mayo Clinic and Johns Hopkins and some pretty prestigious places and people got it. But we just couldn't get traction with with certification. But now that's kind of changed.Yeah, it's kind of changed.Just a little bit, just a little bit. Well, Chris, Ken, did you have any other questions for Chris, this is incredible.One question for you, Chris, how can we help you...You know really, I've said this over and over and it sounds kind of shallow, maybe but we need money. We have to buy more tooling to increase the flow for our raw material providers. We ha...have to. We're going to go through certification and stuff to make sure things were on where we need to be for our paperwork for FDA stuff we need more equipment and more people. And we need a bigger building. Because right now we're working out of our home. This is my living room. So that's what we need. And people have been doing so many amazing things right now with at the grassroots level. We have quite a few corporations helping us like Virgin Galactic, GM, some things like that, but you know, they're doing what they can for keeping us propped up or actually pushing us up, helping us keep going. But and at the at the suggestion, almost at the command of a whole bunch of people who said you need a GoFundMe page we want to help you know, we only we get it, we know what you're doing and where, where you're going. So I just stuck up a GoFundMe page that there's a link to that on our website. I'll just go ahead and send you the URL to that it's, it's gone so much. I can't wrap my head around it and it just started last Friday or Saturday, I can't remember. That's right.Well, we'll we're gonna push it out also. Definitely.And we're gonna be giving updates via the web page right now we haven't really had you know, I can't do it myself, my son or myself would normally do it, but he he's making the products and leading the crew back there. So we don't get as much information on there as we like or on our web page but we've got some friends from church church helping us now so hopefully we'll be able to get the latest and greatest.Man, that's it's just an incredible story and I'm so obviously I wish that you didn't have to suffer with the diabetes and the retinopathy but I'm so glad that you had it and that you found somebody at Possum Kingdom to show you everything. It's just awesome. That's that's some of the events that happened. My previous career that I wanted to retire in, and God is good, that's the best thing I can say so many things, and so many people, and any one of those things we wouldn't have been on this path. So...That is incredible. And the fact, you're probably working harder in your retirement than you ever have.I gotta go back to my career to rest. But I would never do that. I would never do that. This is this is what we were supposed to do. We just didn't know it yet.I believe it I looked at you and I realized that this your life was built to be right here where you are in this moment. And I...you're going to change the destiny of so many people, and I want to thank you for all the work that you're doing. Well, thank you. It's not just us. It's people like yourselves that get the word out and get it. You know, you see it as a professional in the industry, but you also see it as an individual, and this is...that's, that's a big, big plus is to see the look. And if you got time to tell one story yesterday, we were working like crazy. And I can tell you untold numbers like this. And we've had to secure the facility here, because we were having hundreds and hundreds of people just show up to try to help, which is great. But it's, you know, the publicity and stuff. And they'd be knocking on our doors all day and all night. So I just drove from, you know, Wisconsin, here I am. great people, great people in that. I mean, we'd all be just tearing up and falling from the stuff these people would say what they wanted to do, and some of them are still here, by the way. Showing up in their campers who said I'm here to help as a volunteer, whatever do you need? Anyway, this lady shows up. And she says, I just came from Chicago directly. And because of the sheer volume of phone calls we've been getting, people aren't getting through. Internet as you know, those down phones are just completely clogged up. Emails, yeah I've been getten close to 1000 a day. So she couldn't get through. She said we we have such a dire need. I mean, I have people right now that need this. So I just jumped on a plane and flew down here hoping I could just see you. So our people at the gate, let her in and came and found me and she told her story and just started she start crying and balling and stuff. And we'll just say we were able to help her in she's headed back home today.Man that's a fantastic story. Chris, as we close out, don't hang up. But I do want to thank everybody here at gut check project. Do us a favor, just share the story. It's an honor to have Chris on with us today from sea long medical. This is Chris Austin present and owner of sea long medical in Waxahachie, Texas. I said, not owner just president. My wife and my daughter in law who's a Doctor of Physical Therapy. They're the owners.Oh, nice. So he knows the owners pretty well at sea long medical.That's right. I sleep with one of them.Chris, you might want to talk to the owners about how hard they're making you work. Yeah,Hey Ken, anything to close out the show. Like I said, hang on, hang on to the end. Everyone, episode four like and share like and share. Chris law, Chris Austin of sea long medical. Let's get the word out. Let's work together on on this COVID crisis and we're gonna pull through together. We'll talk to everybody soon.

George Whitesides " Do we have a deep understanding of soft smart materials complexity"?

The Sunday Times’ tech correspondent Danny Fortson brings on George Whitesides, chief executive of Virgin Galactic, to talk about the new space race (3:00), doing more with less (4:15), rethinking space travel (6:45), moon hotels (8:15), democratising space (10:00), being an astronaut (12:15), why space travel is important (13:15), bringing the price down (17:30), avoiding disaster (18:30), governing who gets the lunar spoils (22:00), where space exploration sits in the history of humanity (25:00), and moving to the moon (27:20). See acast.com/privacy for privacy and opt-out information.

My guest today is George Whitesides, who is the CEO and President of Virgin Galactic, the spaceflight company founded by Sir Richard Branson. With Scaled Composites, the company has developed the WhiteKnightTwo and SpaceShipTwo vehicles, based on the X Prize-winning SpaceShipOne. In his role, he is responsible for guiding all aspects of the company to commercial operation at Spaceport America.Prior to Virgin Galactic, he served as Chief of Staff for NASA. Upon departure from the agency he was awarded the Distinguished Service Medal, the highest award the agency confers. He is also a fellow of the UK's Royal Aeronautical Society.In our conversation we talk about the strengths and weaknesses of NASA, how space exploration is like aviation 100 years ago, and what the future of Virgin Galactic looks like. Below are the show notes and associated time stamps: Background (minute 02:40)Strengths and weaknesses of NASA (06:45)Working with Richard Branson (10:45)Leadership (15:00)How they're getting to space (19:00)Training (24:00)How space will change our culture (25:00)Lots of technical questions... (27:00)Next 5-10 years for VG (37:15)Aviation 100 years ago (39:15)SpaceX and Blue Origin (43:30)Make sure to subscribe so you don't miss an episode I've also started a monthly newsletter where I send out a few useful or insightful things that have helped me over the last month. You can sign up by clicking here.LinkedIn-- @justinfighterpilotInstagram-- @justinfighterpilotFacebook--@justinfighterpilotThis episode was edited by Trevor CablerIf you'd like to help out, you can review the show by tapping here and scrolling to the bottom where it says: "Write a Review." Thanks for the support

It such an honor to have prof. George Whitesides, Founding Core Faculty Wyss Institute at Harvard University, bright minds came out from him like “Robert Sheperd, AdamStokes, Conor Walsh”. He also co-founder of SoftRoboticsInc. Prof.Whitesides shared with us his very rich experience in soft robotics, I was amazed at how wisdom, intelligence, and simplicity he has. I hope you would enjoy this episode.

《商界 · 早知道》每周一到周五早9点，我们为您奉上最新鲜的商业资讯。看更多精彩资讯和优质文章，敬请关注《商界》和商界、锐公司公众号。 【上海：进博会期间民用无人机等禁飞】上海市政府发布了《关于加强第二届中国国际进口博览会期间无人机等“低慢小”航空器安全管理的通告》，要求自2019年11月2日8时至11月11日24时期间，广大市民在本市范围内禁止飞行、施放民用无人机等“低慢小”航空器，但经依法批准用于电视转播、航拍、警务、应急救援、气象探测等活动的除外。（上海市人民政府网） 你的购衣预算是多少？【羽绒服涨价？企业：平均售价已达到1100-1200元】天越来越冷，你买羽绒服了吗？苏宁公布的数据显示，近两周羽绒服销量环比增长超过1.5倍。记者来到上海一家商场了解到，今年羽绒服价格有着不同程度上涨。以波司登为例，去年秋季羽绒服的平均售价在700-800元之间，而今年已经达到了1100-1200元。业内人士表示，近年来国外羽绒服品牌进入中国市场，一定程度上抬升了消费者心理价位。同时，虽然相比年初，目前鸭绒价格下降了20%-25%，鹅绒价格下降了5%-10%，但仍处于历史的高位。（央视财经） 【报告称支付宝成国内第二大APP，与微信差距缩小】10月29日，第三方研究机构Questmobile发布了2019中国移动互联网秋季大报告，称BAT用户均超10亿。同时，榜单前十的App格局已基本稳定，支付宝月活超QQ成为国内第二大APP，并逐渐拉小与微信的差距。 公司：【18个铁路局盈利能力首次公开：或赚百亿 或亏百亿】去年，18个铁路局中有6家实现了盈利，其中太原铁路局表现最好，实现净利润95.58亿元。太原铁路局利润高的重要原因是其控股子公司，作为运煤专线的大秦铁路优秀的盈利能力。　　武汉、郑州两个铁路局的净利润都超过了50亿；作为总资产唯一一个超过万亿的铁路局，上海铁路局去年净利润为17.09亿元；西安、南昌两地铁路局净利润在14-16亿。 除了上述六家铁路局，其他铁路局都处于亏损状态，亏损额多在50亿以下；成都、哈尔滨、沈阳三地的铁路局亏损超过百亿。目前，国铁集团整体的债务超5万亿，资产负债率在65%左右。各地铁路局的资产负债率则大多在30%-40%。（界面新闻） 忆往昔峥嵘岁月稠：【携程20周年四君子再聚首，梁建章、范敏、沈南鹏和季琦互曝“黑料”】10月29日，携程20周年庆典上，联合创始人梁建章、范敏、沈南鹏、季琦再聚首，聊到携程往事：最初只有十几个人，办公室布满电脑线，上市路演前还打了一下午桥牌。之后，季琦创立了如家、华住；沈南鹏成为投资界大佬。 我严格起来连我自己人都打：【微信最严外链规范实行：封杀京东、拼多多、腾讯新闻等违规链接】10月28日起，升级后的《微信外部链接内容管理规范》正式执行。28日晚，微信官方公布了第一批被封杀的外链名单，涉及了腾讯新闻、西瓜视频、京东、拼多多等平台的外链，被封禁的内容包括：诱导下载/跳转、砍价拼团、有偿投票、各类形式的好友助力、种豆/养鸡/养宠物的养成游戏等。 业内人士称：前期5G套餐会有折扣，整体上5G套餐刚开始的一两年价格肯定不会便宜，后面会降下来。【5G套餐收费详情出炉：最低月租128元 上网“低价低速，高价高速”】昨日媒体记者从运营商内部人士处独家获悉了5G套餐详情，三家运营商5G套餐每月均不低于128元。同时，运营商首次采取按上网速度定价的方式，中国联通分了两个5G网速档次，中国移动分了三个5G网速档次。如中国联通199元及以下价格的5G套餐，上网速度限制在500Mbps，299元及以上5G套餐速度可达1Gbps，超出套餐外的流量为3元每GB。（每日经济新闻） 业务可持续吗？美国股民会买账吗？【催收巨头湖南永雄欲赴美上市】就在重拳出击治理催收行业乱象之际，催收行业巨头湖南永雄正准备登陆美国资本市场。湖南永雄资产管理集团递交的招股书称，公司是中国最大的催收服务提供商，公司给中国前十大商业银行中的七家提供催收服务。湖南永雄在其招股书的“风险因素”部分明确提到，相关投诉可能会导致监管风险的增加，对业绩产生重大不利影响。数据显示，湖南永雄的佣金率较高，2017年、2018年和2019年上半年，佣金费率分别为44.3%、39.8%和35.3%。（每日经济新闻） 史上最惨新股！【重庆农商行上市首日就开板，创新股“最少涨停”纪录】10月29日，渝农商行开启上市之旅。开盘之后，渝农商行与所有新股上市之初一般，无悬念以44.02%的涨幅涨停。然而，至上午10：02分左右，该股涨停板突然打开，随后其上涨幅度不断收窄，至10：09分左右涨幅跌至25%以下。不过截至记者发稿前，该股涨幅曾重新回升至40%以上，目前的最新涨幅为35%左右。上市首日即开板的情况，现行涨跌幅制度实行以来绝无仅有。这也使得渝农商行创造了A股新股“最少涨停”的尴尬历史记录。（21财经） 上市故事如何讲？【嘉楠耘智超九成营收靠卖矿机 IPO主打AI芯片概念】10月29日，比特币矿机制造商嘉楠耘智正式向美国证券交易委员会（SEC）提交首次公开募股说明书。招股书显示，该公司计划以股票代码CAN在纳斯达克上市，并设定4亿美元的筹资金额。若上市成功，嘉楠将成为中国自主知识产权人工智能芯片企业在美国IPO成功的第一股，同时也将成为全球区块链第一股。（华夏时报） 【Sensor Tower：拼多多继续霸榜全球APP Store购物类应用榜单】近日，互联网数据资讯平台Sensor Tower发布的最新全球购物类应用排行榜显示：2019年9月，拼多多继续领跑全球APP Store购物类应用榜单。手机淘宝、美国跨境移动电商平台Wish分列二三位，亚马逊排名第五。 【荔枝赴美提交IPO申请，有望成为“中国音频行业”第一股】音频社区荔枝（原荔枝FM）正式向美国证券交易委员会（SEC）提交了IPO申请，交易代码为“LIZI”。荔枝计划通过IPO募集1亿美元资金，主承销商为瑞信和花旗。荔枝本次赴美上市的融资资金将主要用于AI技术研发、国内外社区拓展和IOT生态布局。 【学而思网校今年放弃盈利，进入战略性亏损】近日，好未来集团旗下的学而思网校事业部进行了产品线压缩与人员优化，目前高中部优化比例在20%-40%；此外着力发展网校下K12一对一业务，对标掌门一对一。 一位接近学而思的人士表示，张邦鑫在今年的高管会议上对于网校暑假的投放表示:“网校今年本可以盈利，但我们选择了战略性亏损。”（晚点Latepost） 海外：美国式“招投标”暗藏猫腻：【不满“插手”！亚马逊或就国防部云计算合同提出挑战】在失去美国国防部百亿美元云计算大合同后，亚马逊表示非常失望。亚马逊称，他们有足够的技术能力达到国防部的要求，将考虑对国防部提出抗议或申诉。亚马逊竞标失败，和与亚马逊CEO贝索斯私人矛盾不无关系。《纽约时报》称，贝索斯旗下《华盛顿邮报》经常发表批评政府的文章。美国前国防部长詹姆斯•马蒂斯传记作者爆料，曾要求马蒂斯在云计算合同招标中“整掉”亚马逊，但马蒂斯予以拒绝。不过，五角大楼强调，云计算合同评标过程严格遵循相关标准，符合法律法规要求。（第一财经） 【全球首家太空旅游公司上市，太空旅游票价每人25万美元】全球首家太空旅游公司维珍银河控股公司（Virgin Galactic Holdings）周一在纽交所挂牌上市，股价一度大涨9.7%，但收盘下跌0.3%，市值达23亿美元左右。该公司CEO乔治-怀特赛兹（George Whitesides）在一份声明中表示：“维珍银河今天再次创造历史，成为世界上第一家也是唯一一家公开交易的商用载人航天公司。这是第一次，任何人都有机会投资一家正在改变市场的载人航天公司。”截至6月底，该公司已有603个客户付了定金，其中一些人为了实现太空旅行梦想已经等了10年。（新浪美股） 泡菜是韩国人餐桌上必备的菜肴，但今年做泡菜的成本有点高：【1棵白菜卖到30元，韩国主妇：腌不起泡菜了】在今年秋天的白菜收获季，韩国连遭台风袭击，导致白菜主产地的产量下滑，白菜批发和零售价格大幅上涨。目前正值腌制泡菜的季节，很多韩国主妇都表示腌不起泡菜，购买成品泡菜成为她们的首选。（央视财经）更多精彩优质内容，欢迎关注【商界】杂志、【锐公司】公众号。学习企业增长方法，获得更多精彩内容，欢迎持续关注【商界识堂】。

《商界 · 早知道》每周一到周五早9点，我们为您奉上最新鲜的商业资讯。看更多精彩资讯和优质文章，敬请关注《商界》和商界、锐公司公众号。 【上海：进博会期间民用无人机等禁飞】上海市政府发布了《关于加强第二届中国国际进口博览会期间无人机等“低慢小”航空器安全管理的通告》，要求自2019年11月2日8时至11月11日24时期间，广大市民在本市范围内禁止飞行、施放民用无人机等“低慢小”航空器，但经依法批准用于电视转播、航拍、警务、应急救援、气象探测等活动的除外。（上海市人民政府网） 你的购衣预算是多少？【羽绒服涨价？企业：平均售价已达到1100-1200元】天越来越冷，你买羽绒服了吗？苏宁公布的数据显示，近两周羽绒服销量环比增长超过1.5倍。记者来到上海一家商场了解到，今年羽绒服价格有着不同程度上涨。以波司登为例，去年秋季羽绒服的平均售价在700-800元之间，而今年已经达到了1100-1200元。业内人士表示，近年来国外羽绒服品牌进入中国市场，一定程度上抬升了消费者心理价位。同时，虽然相比年初，目前鸭绒价格下降了20%-25%，鹅绒价格下降了5%-10%，但仍处于历史的高位。（央视财经） 【报告称支付宝成国内第二大APP，与微信差距缩小】10月29日，第三方研究机构Questmobile发布了2019中国移动互联网秋季大报告，称BAT用户均超10亿。同时，榜单前十的App格局已基本稳定，支付宝月活超QQ成为国内第二大APP，并逐渐拉小与微信的差距。 公司：【18个铁路局盈利能力首次公开：或赚百亿 或亏百亿】去年，18个铁路局中有6家实现了盈利，其中太原铁路局表现最好，实现净利润95.58亿元。太原铁路局利润高的重要原因是其控股子公司，作为运煤专线的大秦铁路优秀的盈利能力。　　武汉、郑州两个铁路局的净利润都超过了50亿；作为总资产唯一一个超过万亿的铁路局，上海铁路局去年净利润为17.09亿元；西安、南昌两地铁路局净利润在14-16亿。 除了上述六家铁路局，其他铁路局都处于亏损状态，亏损额多在50亿以下；成都、哈尔滨、沈阳三地的铁路局亏损超过百亿。目前，国铁集团整体的债务超5万亿，资产负债率在65%左右。各地铁路局的资产负债率则大多在30%-40%。（界面新闻） 忆往昔峥嵘岁月稠：【携程20周年四君子再聚首，梁建章、范敏、沈南鹏和季琦互曝“黑料”】10月29日，携程20周年庆典上，联合创始人梁建章、范敏、沈南鹏、季琦再聚首，聊到携程往事：最初只有十几个人，办公室布满电脑线，上市路演前还打了一下午桥牌。之后，季琦创立了如家、华住；沈南鹏成为投资界大佬。 我严格起来连我自己人都打：【微信最严外链规范实行：封杀京东、拼多多、腾讯新闻等违规链接】10月28日起，升级后的《微信外部链接内容管理规范》正式执行。28日晚，微信官方公布了第一批被封杀的外链名单，涉及了腾讯新闻、西瓜视频、京东、拼多多等平台的外链，被封禁的内容包括：诱导下载/跳转、砍价拼团、有偿投票、各类形式的好友助力、种豆/养鸡/养宠物的养成游戏等。 业内人士称：前期5G套餐会有折扣，整体上5G套餐刚开始的一两年价格肯定不会便宜，后面会降下来。【5G套餐收费详情出炉：最低月租128元 上网“低价低速，高价高速”】昨日媒体记者从运营商内部人士处独家获悉了5G套餐详情，三家运营商5G套餐每月均不低于128元。同时，运营商首次采取按上网速度定价的方式，中国联通分了两个5G网速档次，中国移动分了三个5G网速档次。如中国联通199元及以下价格的5G套餐，上网速度限制在500Mbps，299元及以上5G套餐速度可达1Gbps，超出套餐外的流量为3元每GB。（每日经济新闻） 业务可持续吗？美国股民会买账吗？【催收巨头湖南永雄欲赴美上市】就在重拳出击治理催收行业乱象之际，催收行业巨头湖南永雄正准备登陆美国资本市场。湖南永雄资产管理集团递交的招股书称，公司是中国最大的催收服务提供商，公司给中国前十大商业银行中的七家提供催收服务。湖南永雄在其招股书的“风险因素”部分明确提到，相关投诉可能会导致监管风险的增加，对业绩产生重大不利影响。数据显示，湖南永雄的佣金率较高，2017年、2018年和2019年上半年，佣金费率分别为44.3%、39.8%和35.3%。（每日经济新闻） 史上最惨新股！【重庆农商行上市首日就开板，创新股“最少涨停”纪录】10月29日，渝农商行开启上市之旅。开盘之后，渝农商行与所有新股上市之初一般，无悬念以44.02%的涨幅涨停。然而，至上午10：02分左右，该股涨停板突然打开，随后其上涨幅度不断收窄，至10：09分左右涨幅跌至25%以下。不过截至记者发稿前，该股涨幅曾重新回升至40%以上，目前的最新涨幅为35%左右。上市首日即开板的情况，现行涨跌幅制度实行以来绝无仅有。这也使得渝农商行创造了A股新股“最少涨停”的尴尬历史记录。（21财经） 上市故事如何讲？【嘉楠耘智超九成营收靠卖矿机 IPO主打AI芯片概念】10月29日，比特币矿机制造商嘉楠耘智正式向美国证券交易委员会（SEC）提交首次公开募股说明书。招股书显示，该公司计划以股票代码CAN在纳斯达克上市，并设定4亿美元的筹资金额。若上市成功，嘉楠将成为中国自主知识产权人工智能芯片企业在美国IPO成功的第一股，同时也将成为全球区块链第一股。（华夏时报） 【Sensor Tower：拼多多继续霸榜全球APP Store购物类应用榜单】近日，互联网数据资讯平台Sensor Tower发布的最新全球购物类应用排行榜显示：2019年9月，拼多多继续领跑全球APP Store购物类应用榜单。手机淘宝、美国跨境移动电商平台Wish分列二三位，亚马逊排名第五。 【荔枝赴美提交IPO申请，有望成为“中国音频行业”第一股】音频社区荔枝（原荔枝FM）正式向美国证券交易委员会（SEC）提交了IPO申请，交易代码为“LIZI”。荔枝计划通过IPO募集1亿美元资金，主承销商为瑞信和花旗。荔枝本次赴美上市的融资资金将主要用于AI技术研发、国内外社区拓展和IOT生态布局。 【学而思网校今年放弃盈利，进入战略性亏损】近日，好未来集团旗下的学而思网校事业部进行了产品线压缩与人员优化，目前高中部优化比例在20%-40%；此外着力发展网校下K12一对一业务，对标掌门一对一。 一位接近学而思的人士表示，张邦鑫在今年的高管会议上对于网校暑假的投放表示:“网校今年本可以盈利，但我们选择了战略性亏损。”（晚点Latepost） 海外：美国式“招投标”暗藏猫腻：【不满“插手”！亚马逊或就国防部云计算合同提出挑战】在失去美国国防部百亿美元云计算大合同后，亚马逊表示非常失望。亚马逊称，他们有足够的技术能力达到国防部的要求，将考虑对国防部提出抗议或申诉。亚马逊竞标失败，和与亚马逊CEO贝索斯私人矛盾不无关系。《纽约时报》称，贝索斯旗下《华盛顿邮报》经常发表批评政府的文章。美国前国防部长詹姆斯•马蒂斯传记作者爆料，曾要求马蒂斯在云计算合同招标中“整掉”亚马逊，但马蒂斯予以拒绝。不过，五角大楼强调，云计算合同评标过程严格遵循相关标准，符合法律法规要求。（第一财经） 【全球首家太空旅游公司上市，太空旅游票价每人25万美元】全球首家太空旅游公司维珍银河控股公司（Virgin Galactic Holdings）周一在纽交所挂牌上市，股价一度大涨9.7%，但收盘下跌0.3%，市值达23亿美元左右。该公司CEO乔治-怀特赛兹（George Whitesides）在一份声明中表示：“维珍银河今天再次创造历史，成为世界上第一家也是唯一一家公开交易的商用载人航天公司。这是第一次，任何人都有机会投资一家正在改变市场的载人航天公司。”截至6月底，该公司已有603个客户付了定金，其中一些人为了实现太空旅行梦想已经等了10年。（新浪美股） 泡菜是韩国人餐桌上必备的菜肴，但今年做泡菜的成本有点高：【1棵白菜卖到30元，韩国主妇：腌不起泡菜了】在今年秋天的白菜收获季，韩国连遭台风袭击，导致白菜主产地的产量下滑，白菜批发和零售价格大幅上涨。目前正值腌制泡菜的季节，很多韩国主妇都表示腌不起泡菜，购买成品泡菜成为她们的首选。（央视财经）更多精彩优质内容，欢迎关注【商界】杂志、【锐公司】公众号。学习企业增长方法，获得更多精彩内容，欢迎持续关注【商界识堂】。

In this episode, we interviewed Robert Sheperd, associate professor at Cornell University, Rob Shepherd received his B.S. (2002) and Ph.D. (2010) in Material Science at the University of Illinois where his research focused on developing polymeric and colloidal suspensions as 'inks' for 3D printers. He also fabricated microfluidic devices to synthesize single micron to millimeter -scale parts (e.g., glass and silicon microgears). Concurrently to performing this research, he received his M.B.A. (2009) at U of I and started a company, worked with several other startups, and gained significant experience with the details of market research, financials, accounting issues, and legal aspects of entrepreneurship. In 2010, he continued his education as a post-doctoral fellow at Harvard University in George Whitesides's research group in the Department of Chemistry and Chemical Biology. In this group, he developed pneumatic actuators in soft elastomers that took the form of a machine capable of moving in multiple gaits: walking and undulating. These actuators have also been used for low-cost manipulators, and in concert with a microfluidic system for biomimetic camouflage & display.

George Whitesides discusses an inexpensive and easy-to-use medical diagnostic device that can be used in the developing world.

From space to the inner city – An interview with the CEO of Virgin Galactic – with George Whitesides (virgingalactic.com/who-we-are/our-team), celebrating International Space Day. Fascinating conversation with a rocket scientists. A conversation with a group of people: Sara Reyes (Cal Endow Managing Dir of Communications - calendow.org), Jennifer Ybarra (Dir of Youth Development Task Force) and Lou Calanche (Founder & Exec Dir of Legacy LA - legacyla.org) from the California Endowment and Legacy LA to talk about how unique plans are underway to transform communities long thought to be underserved, using the input and insight of residents and stakeholders who have a vision as to how these communities can grow and thrive. Also talked about the establishment of a new Youth Task Force empowered by La City Council so young people can have a say in how their inner city neighborhoods are improved. Young people, dare we say, are the future! Jennifer Reitman , Founder and Editor in Chief of DAME media – an all female run and content generated medium that works hard to change the narrative around women in politics, women in finance, women in industry – women unlimited by stereotypes and having an impact in every walk of life. 100% edited by women. 100% Bylined by women. damemagazine.com Click over and become a member, today!

(:30) George Whitesides is pushing the envelope (0:49) Space inspires George (1:29) George's history with NASA and his journey to the private sector (2:44) We want to get everyone a chance to be up in space (3:35) Whitesides loves Earth, he doesn't want to leave as a dump (4:20) Mining asteroids (5:00) Richard Branson (7:21) Other projects in space travel with various businesses (8:25) Most fun space fact and most strange space fact (9:20) Paranoia (9:55) Importance of curiosity (10:10) The dream of opening up space (10:38) Touching stories in Virgin Galactic's interface (11:30) She's waited 50 years for your space shuttle (12:24) 3-D Printing and AI are getting developed (12:50) Advances in Health (13:25) Cheating death or improving the quality of life? (13:54) Making contributions through your actions (14:00) Eliminating scarcity throughout the world (14:37) Spaceship Earth, taking care of it (15:15) Eric James' trip to space photography (15:50) Impacting the planet from outside the solar system (16:30) How we can all help Virgin Galactic   Three key points: We'll be able to leave this Earth soon, but it's still important that we watch and take care of it. The Future is closer than it's ever been. Life always has meaning because life always has more opportunity  

6,000 job-seekers came to the new Long Beach, California home of Virgin Galactic’s LauncherOne rocket on a recent morning. We sit down with CEO George Whitesides for a conversation about this new effort and the return of SpaceShipTwo.Learn more about your ad choices. Visit megaphone.fm/adchoices

Join the party as we celebrate the 53rd anniversary of humanity’s transition to spacefaring species with Yuri’s Night Executive Director Loretta Hidalgo Whitesides, Virgin Galactic CEO and Yuri’s Night co-founder George Whitesides, and astronaut Ron Garan, who heads Fragile Oasis.Learn more about your ad choices. Visit megaphone.fm/adchoices

First it was music. Then it was mobile. Then commercial airlines. And now Virgin could very well be the first pop culture brand in the commercial space travel business. Former NASA Chief of Staff and now Virgin Galactic CEO, George Whitesides walks us through what it takes to truly build, commercialize, and market something as grand as personalized travel out of the atmosphere.

George Whitesides discusses an inexpensive and easy-to-use medical diagnostic device that can be used in the developing world.

Managing Editor Jennifer Griffiths interviews author George Whitesides about the January 1, 2010 cover Feature on paper-based microfluidic diagnostic devices for the developing world.

We sit down with science photographer Felice Frankel and nanotechnology pioneer and Harvard chemist George Whitesides to hear about their new book on nanoscience, No Small Matter.

Harvard researcher George Whitesides, one of today’s leading chemists, gives a view of the current state of nanoscience and nanotechnology. They are attracting great attention because...

Get ready for ISDC! We have George Whitesides from the National Space Society to discuss the 2007 ISDC Conference in Dallas. Will Pomerantz gets us ready for the 2007 Wirefly X PRIZE Cup... and we take a look at NASA's DAWN Mission - a new way to explore!